Salma Elnour Rahma Mohamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Salma Elnour Rahma Mohamed has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Sara Ali
Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman P.O. Box 4184, United Arab Emirates
12 shared publications - Praveen Kumar Kandakurti
Department of Physiotherapy Ajman College of Health Sciences, Gulf Medical University
3 shared publications Hassan Higazi
2 shared publications- Hassan Higazi
Gulf Medical University, United Arab Emirates
2 shared publications - Marwan Ismail
Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates
2 shared publications - Abd Elgadir Alamin Altoum
Department of Medical Laboratory Sciences, Clinical Chemistry Gulf Medical University
1 shared publication
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2675
Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set
Biofilm-associated infections impose a substantial burden on clinical practice, yet in vitro data generated to guide therapeutic development frequently fail to predict in vivo outcomes. This review advances a problem-solving argument: although host immunity, pharmacokinetics, tissue penetration, and infection-site biology also shape clinical outcomes, a major and modifiable contributor to this predictive failure is the systematic simplification of the measured object away from the resistance mechanisms operating within the infection microenvironment. Across five axes of divergence (surface, medium conditioning, operational steps, timing, and readout with controls), we identify gaps and failure modes that weaken the link between bench data and clinical outcome. Recent evidence shows that crystal violet and XTT staining report different biological parameters and agree with each other, and with viable counts, only under defined conditions; standardized parameters for minimum biofilm eradication concentration testing remain absent, and that growth mode, aggregation propensity, and growth rate, which vary between strains, strongly influence biofilm formation and resistance in ways conventional assays poorly capture. We propose a research agenda centered on physiologically conditioned platforms, multi-endpoint readouts, confounding controls, maturity-indexed endpoints, and growth-mode heterogeneity, offering a proposed, as yet unvalidated, minimum reporting framework intended to make assay conditions auditable and results comparable across studies, as a prerequisite for, rather than a demonstration of, clinical predictive validity.
- 18 November 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2675
Open AccessWhy In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set
Biofilm-associated infections impose a substantial burden on clinical practice, yet in vitro data generated to guide therapeutic development frequently fail to predict in vivo outcomes. This review advances a problem-solving argument: although host immunity, pharmacokinetics, tissue penetration, and infection-site biology also shape clinical outcomes, a major and modifiable contributor to this predictive failure is the systematic simplification of the measured object away from the resistance mechanisms operating within the infection microenvironment. Across five axes of divergence (surface, medium conditioning, operational steps, timing, and readout with controls), we identify gaps and failure modes that weaken the link between bench data and clinical outcome. Recent evidence shows that crystal violet and XTT staining report different biological parameters and agree with each other, and with viable counts, only under defined conditions; standardized parameters for minimum biofilm eradication concentration testing remain absent, and that growth mode, aggregation propensity, and growth rate, which vary between strains, strongly influence biofilm formation and resistance in ways conventional assays poorly capture. We propose a research agenda centered on physiologically conditioned platforms, multi-endpoint readouts, confounding controls, maturity-indexed endpoints, and growth-mode heterogeneity, offering a proposed, as yet unvalidated, minimum reporting framework intended to make assay conditions auditable and results comparable across studies, as a prerequisite for, rather than a demonstration of, clinical predictive validity.
- Open Access
Laboratory-Acquired Yersinia pestis Infection: Occupational Exposure, Clinical Presentation and Microbiological Identification
Laboratory work with Yersinia pestis is governed by detailed containment provisions, and laboratory-acquired infection is rare: a scoping review covering 2000 to 2021 attributed two of 309 cases to Y. pestis. Preventing exposure and recognising infection after an unidentified exposure are, however, distinct problems, and the second has received less attention. This narrative review, supported by a documented search of PubMed, PubMed Central and major biosafety and public-health agency websites to October 2026, classified evidence into seven categories and analysed them without pooling. The record that can be reconstructed in detail comprises two cases: a fatal infection reported from Chicago in 2009, in which no exposure event was identified, occupation was absent from the clinical record and the organism was identified only after death; a survived infection from a United States laboratory in 1959, in which the exposure was likewise unrecognised but the occupational context was known at admission and the organism was identified within 18 h. Evidence from naturally acquired plague documents bidirectional misidentification of Y. pestis by commercial automated and mass-spectrometry systems, attributable to reference-library composition rather than instrument performance. Recognition therefore appears to depend on information held separately by the worker, the employing institution, the treating clinician and the clinical microbiology laboratory, while many containment and response measures become operative only once exposure or plague is suspected. Post-work health monitoring and symptom reporting are specified as requirements in Russian and Canadian national documents but appear only as recommendations in the United States guidance reviewed. These observations rest on a small case record and indicate areas for evaluation rather than an established pattern.
Open AccessLaboratory-Acquired Yersinia pestis Infection: Occupational Exposure, Clinical Presentation and Microbiological Identification
Laboratory work with Yersinia pestis is governed by detailed containment provisions, and laboratory-acquired infection is rare: a scoping review covering 2000 to 2021 attributed two of 309 cases to Y. pestis. Preventing exposure and recognising infection after an unidentified exposure are, however, distinct problems, and the second has received less attention. This narrative review, supported by a documented search of PubMed, PubMed Central and major biosafety and public-health agency websites to October 2026, classified evidence into seven categories and analysed them without pooling. The record that can be reconstructed in detail comprises two cases: a fatal infection reported from Chicago in 2009, in which no exposure event was identified, occupation was absent from the clinical record and the organism was identified only after death; a survived infection from a United States laboratory in 1959, in which the exposure was likewise unrecognised but the occupational context was known at admission and the organism was identified within 18 h. Evidence from naturally acquired plague documents bidirectional misidentification of Y. pestis by commercial automated and mass-spectrometry systems, attributable to reference-library composition rather than instrument performance. Recognition therefore appears to depend on information held separately by the worker, the employing institution, the treating clinician and the clinical microbiology laboratory, while many containment and response measures become operative only once exposure or plague is suspected. Post-work health monitoring and symptom reporting are specified as requirements in Russian and Canadian national documents but appear only as recommendations in the United States guidance reviewed. These observations rest on a small case record and indicate areas for evaluation rather than an established pattern.
- Open Access
- 13 November 2026
- Published by MDPI AG in International Medical Education
- Vol. 5 (4) , 130
Granted, Not Claimed: How Medical Laboratory Science Students Negotiate Recognition and Legitimacy in Interprofessional Education
Professional identity formation (PIF) is the process through which learners come to see themselves, and to be seen by others, as members of a profession. Interprofessional education (IPE) may support PIF, but this remains underexplored in Medical Laboratory Science (MLS), a less visible profession whose standing in interprofessional spaces cannot be assumed. This exploratory qualitative study, informed by the Landscapes of Practice (LoP) framework, involved three focus groups with 18 MLS students at Gulf Medical University, UAE, who had completed at least two IPE sessions. Data were analysed using reflexive thematic analysis. Three themes were constructed: (1) Granted, not claimed: recognition as the condition for engagement; (2) Imagining a role that reaches the patient; and (3) Making the laboratory contribution count: the conditions for alignment. Engagement depended largely on whether peers recognised students’ contribution; students in all year groups recalled early exclusion, Year 4 students more often described recognition growing over time, and Year 3 students more often described episodic exclusion, in which recognition given in one discussion was withheld in the next. Imagination sustained a valued picture of their role against status threats, while orientation, case design, and facilitation shaped whether laboratory knowledge became credible across professions. Recognition, knowledgeability, and belonging appeared socially conferred and, for some students, fragile; these patterns may also reflect group composition, delivery mode, and the early stage of students’ profession-specific identity. Clear orientation, cases that require laboratory input, and facilitator preparation may support more equitable participation for less visible professions.
- 13 November 2026
- Published by MDPI AG in International Medical Education
- Vol. 5 (4) , 130
Open AccessGranted, Not Claimed: How Medical Laboratory Science Students Negotiate Recognition and Legitimacy in Interprofessional Education
Professional identity formation (PIF) is the process through which learners come to see themselves, and to be seen by others, as members of a profession. Interprofessional education (IPE) may support PIF, but this remains underexplored in Medical Laboratory Science (MLS), a less visible profession whose standing in interprofessional spaces cannot be assumed. This exploratory qualitative study, informed by the Landscapes of Practice (LoP) framework, involved three focus groups with 18 MLS students at Gulf Medical University, UAE, who had completed at least two IPE sessions. Data were analysed using reflexive thematic analysis. Three themes were constructed: (1) Granted, not claimed: recognition as the condition for engagement; (2) Imagining a role that reaches the patient; and (3) Making the laboratory contribution count: the conditions for alignment. Engagement depended largely on whether peers recognised students’ contribution; students in all year groups recalled early exclusion, Year 4 students more often described recognition growing over time, and Year 3 students more often described episodic exclusion, in which recognition given in one discussion was withheld in the next. Imagination sustained a valued picture of their role against status threats, while orientation, case design, and facilitation shaped whether laboratory knowledge became credible across professions. Recognition, knowledgeability, and belonging appeared socially conferred and, for some students, fragile; these patterns may also reflect group composition, delivery mode, and the early stage of students’ profession-specific identity. Clear orientation, cases that require laboratory input, and facilitator preparation may support more equitable participation for less visible professions.
- Open Access
- 29 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2468
Regional Heterogeneity in Carbapenemase Gene Epidemiology (OXA-48, NDM, and IMP) Among Gulf Cooperation Council Countries: A Comparative Mini-Review
Carbapenemase-producing Pseudomonas aeruginosa and Klebsiella pneumoniae are a leading cause of difficult-to-treat infections in the Gulf Cooperation Council (GCC) region, yet the contribution of the three principal carbapenemase gene families (blaOXA-48, blaNDM, and blaIMP) is often assumed to be uniform across neighboring countries. This mini-review synthesizes facility-level, national, and genomic surveillance data from the United Arab Emirates (UAE), Qatar, Oman, Kuwait, Bahrain, and Saudi Arabia, anchored by a recent cohort from University Hospital Sharjah, UAE. blaOXA-48-like genes were the most frequently reported family regionally (51.7% in a 720-genome Arabian Peninsula study), but this dominance was not universal: OXA-181 predominated in Kuwaiti ICU isolates (89.3%), blaNDM-1 co-occurred in 95.8% of a small Bahraini series, and UAE national surveillance (2010–2021) found blaOXA-48 rarely, in contrast to 65–67% at Sharjah. Saudi data showed a comparable regional gradient, and the dominant determinant shifted over time in Oman and Kuwait. High-risk clones, including hypervirulent ST383, circulated across countries, while carbapenemase-positive P. aeruginosa carried mainly VIM- and GES-type enzymes. Heterogeneity, at the facility and country levels, is the defining feature of GCC carbapenemase epidemiology; acute-care laboratories therefore need molecular panels covering blaOXA-48-like, blaNDM, blaVIM, blaIMP, and blaKPC, and facility-level antibiograms warrant at least annual review.
- 29 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (11) , 2468
Open AccessRegional Heterogeneity in Carbapenemase Gene Epidemiology (OXA-48, NDM, and IMP) Among Gulf Cooperation Council Countries: A Comparative Mini-Review
Carbapenemase-producing Pseudomonas aeruginosa and Klebsiella pneumoniae are a leading cause of difficult-to-treat infections in the Gulf Cooperation Council (GCC) region, yet the contribution of the three principal carbapenemase gene families (blaOXA-48, blaNDM, and blaIMP) is often assumed to be uniform across neighboring countries. This mini-review synthesizes facility-level, national, and genomic surveillance data from the United Arab Emirates (UAE), Qatar, Oman, Kuwait, Bahrain, and Saudi Arabia, anchored by a recent cohort from University Hospital Sharjah, UAE. blaOXA-48-like genes were the most frequently reported family regionally (51.7% in a 720-genome Arabian Peninsula study), but this dominance was not universal: OXA-181 predominated in Kuwaiti ICU isolates (89.3%), blaNDM-1 co-occurred in 95.8% of a small Bahraini series, and UAE national surveillance (2010–2021) found blaOXA-48 rarely, in contrast to 65–67% at Sharjah. Saudi data showed a comparable regional gradient, and the dominant determinant shifted over time in Oman and Kuwait. High-risk clones, including hypervirulent ST383, circulated across countries, while carbapenemase-positive P. aeruginosa carried mainly VIM- and GES-type enzymes. Heterogeneity, at the facility and country levels, is the defining feature of GCC carbapenemase epidemiology; acute-care laboratories therefore need molecular panels covering blaOXA-48-like, blaNDM, blaVIM, blaIMP, and blaKPC, and facility-level antibiograms warrant at least annual review.
- Open Access
- 30 September 2026
- Published by MDPI AG in Preprints.org
Regional Heterogeneity in Carbapenemase Gene Epidemiology (OXA-48, NDM, and IMP) Among Gulf Cooperation Council Countries: A Comparative Mini-Review
Carbapenemase-producing Pseudomonas aeruginosa and Klebsiella pneumoniae are a leading cause of difficult-to-treat infections in the Gulf Cooperation Council (GCC) region, yet the contribution of the three principal carbapenemase gene families (blaOXA-48, blaNDM, and blaIMP) is often assumed to be uniform across neighboring countries. This mini-review synthesizes facility-level, national, and genomic surveillance data from the United Arab Emirates (UAE), Qatar, Oman, Kuwait, Bahrain, and Saudi Arabia, anchored by a recent cohort from University Hospital Sharjah, UAE. blaOXA-48-like genes were the most frequently reported family regionally (51.7% in a 720-genome Arabian Peninsula study), but this dominance was not universal: OXA-181 predominated in Kuwaiti ICU isolates (89.3%), blaNDM-1 co-occurred in 95.8% of a small Bahraini series, and UAE national surveillance (2010–2021) found blaOXA-48 rare, in contrast to 65–67% at Sharjah. Saudi data showed a comparable regional gradient, and the dominant determinant shifted over time in Oman and Kuwait. High-risk clones, including hypervirulent ST383, circulated across countries, while carbapenemase-positive P. aeruginosa carried mainly VIM- and GES-type enzymes. Heterogeneity, at facility as well as country level, is the defining feature of GCC carbapenemase epidemiology; acute-care laboratories therefore need molecular panels covering blaOXA-48-like, blaNDM, blaVIM, blaIMP, and blaKPC, and facility-level antibiograms warrant at least annual review.
- 30 September 2026
- Published by MDPI AG in Preprints.org
Open AccessRegional Heterogeneity in Carbapenemase Gene Epidemiology (OXA-48, NDM, and IMP) Among Gulf Cooperation Council Countries: A Comparative Mini-Review
Carbapenemase-producing Pseudomonas aeruginosa and Klebsiella pneumoniae are a leading cause of difficult-to-treat infections in the Gulf Cooperation Council (GCC) region, yet the contribution of the three principal carbapenemase gene families (blaOXA-48, blaNDM, and blaIMP) is often assumed to be uniform across neighboring countries. This mini-review synthesizes facility-level, national, and genomic surveillance data from the United Arab Emirates (UAE), Qatar, Oman, Kuwait, Bahrain, and Saudi Arabia, anchored by a recent cohort from University Hospital Sharjah, UAE. blaOXA-48-like genes were the most frequently reported family regionally (51.7% in a 720-genome Arabian Peninsula study), but this dominance was not universal: OXA-181 predominated in Kuwaiti ICU isolates (89.3%), blaNDM-1 co-occurred in 95.8% of a small Bahraini series, and UAE national surveillance (2010–2021) found blaOXA-48 rare, in contrast to 65–67% at Sharjah. Saudi data showed a comparable regional gradient, and the dominant determinant shifted over time in Oman and Kuwait. High-risk clones, including hypervirulent ST383, circulated across countries, while carbapenemase-positive P. aeruginosa carried mainly VIM- and GES-type enzymes. Heterogeneity, at facility as well as country level, is the defining feature of GCC carbapenemase epidemiology; acute-care laboratories therefore need molecular panels covering blaOXA-48-like, blaNDM, blaVIM, blaIMP, and blaKPC, and facility-level antibiograms warrant at least annual review.
- Open Access
- 22 September 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2126
Uropathogen Distribution Across Successive Positive Urine Cultures Among Female Patients with Dysglycaemia
Female patients with dysglycaemia may undergo repeated urine cultures, but longitudinal microbiological data from the Gulf are limited. We retrospectively examined successive positive urine cultures from 67 female patients attending a tertiary hospital in Ajman, United Arab Emirates, between May 2016 and September 2025. Organism identity, extended-spectrum beta-lactamase (ESBL) phenotype, HbA1c and culture dates were extracted from laboratory records. Twenty-eight participants (41.8%; 95% CI 30.5–53.7) had a second recorded positive culture and ten (14.9%; 95% CI 7.9–24.9) had a third; the median interval between the first and second cultures was 161 days (IQR 74–402). Escherichia coli was the most frequent organism at each culture. At the index culture, non-ESBL E. coli accounted for 38.8% of specimens, ESBL-producing E. coli for 25.4% and Candida species for 19.4%. Recovery of the same organism or phenotype category between the first and second cultures occurred most often with E. coli (17.9% non-ESBL; 14.3% ESBL-producing). Restricting the analysis to index cultures from 2023 to 2025 did not materially change the organism distribution. Because urinary symptoms and isolate-level susceptibility results were unavailable, positive cultures could not be classified as symptomatic infection, asymptomatic bacteriuria or candiduria, and treatment appropriateness could not be assessed. Prospective studies linking symptoms, susceptibility profiles and clinical outcomes are warranted.
- 22 September 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2126
Open AccessUropathogen Distribution Across Successive Positive Urine Cultures Among Female Patients with Dysglycaemia
Female patients with dysglycaemia may undergo repeated urine cultures, but longitudinal microbiological data from the Gulf are limited. We retrospectively examined successive positive urine cultures from 67 female patients attending a tertiary hospital in Ajman, United Arab Emirates, between May 2016 and September 2025. Organism identity, extended-spectrum beta-lactamase (ESBL) phenotype, HbA1c and culture dates were extracted from laboratory records. Twenty-eight participants (41.8%; 95% CI 30.5–53.7) had a second recorded positive culture and ten (14.9%; 95% CI 7.9–24.9) had a third; the median interval between the first and second cultures was 161 days (IQR 74–402). Escherichia coli was the most frequent organism at each culture. At the index culture, non-ESBL E. coli accounted for 38.8% of specimens, ESBL-producing E. coli for 25.4% and Candida species for 19.4%. Recovery of the same organism or phenotype category between the first and second cultures occurred most often with E. coli (17.9% non-ESBL; 14.3% ESBL-producing). Restricting the analysis to index cultures from 2023 to 2025 did not materially change the organism distribution. Because urinary symptoms and isolate-level susceptibility results were unavailable, positive cultures could not be classified as symptomatic infection, asymptomatic bacteriuria or candiduria, and treatment appropriateness could not be assessed. Prospective studies linking symptoms, susceptibility profiles and clinical outcomes are warranted.
- Open Access
- 24 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1613
Virulence Gene Profile and Antimicrobial Susceptibility of Staphylococcus aureus Clinical Isolates from the United Arab Emirates
Staphylococcus aureus causes infections ranging from skin and soft tissue infections to life-threatening systemic disease. The convergence of virulence determinants with antimicrobial resistance, particularly in methicillin-resistant S. aureus (MRSA), complicates management. In the United Arab Emirates (UAE), S. aureus is a major contributor to community- and hospital-acquired infections, and regional surveillance from the Gulf Cooperation Council has documented a shift toward community-associated MRSA lineages. Despite this clinical burden, granular molecular epidemiological data from the UAE remain scarce. Fifty consecutive S. aureus clinical isolates were obtained from Thumbay Laboratories, Ajman, UAE (October 2022–August 2023). Identification and antimicrobial susceptibility testing against 23 agents were performed on the MicroScan WalkAway system. Five virulence genes, namely mecA, Panton-Valentine leukocidin (PVL; lukF-S), exfoliative toxins A (eta) and B (etb), and toxic shock syndrome toxin (tst), were detected by conventional PCR. PVL was the most prevalent virulence gene (48%, 24/50), detected exclusively in pus isolates. mecA carriage, confirming MRSA, was identified in 44% (22/50), with PVL–mecA co-occurrence in 22% (11/50). eta was present in 6% (3/50), and etb and tst each in 2% (1/50). Resistance was highest for ampicillin and penicillin (86% each), while full susceptibility (100%) was retained for vancomycin, linezolid, daptomycin, teicoplanin, rifampin, Synercid, and trimethoprim. mecA carriage was significantly associated with resistance to amoxicillin, clavulanate, ampicillin, imipenem, penicillin, oxacillin, azithromycin, erythromycin, and ciprofloxacin (p < 0.05). This study provides the first integrated molecular characterization of key S. aureus virulence determinants, along with a comprehensive antimicrobial susceptibility profile in the UAE. The high PVL prevalence and substantial MRSA burden highlight the need for structured regional surveillance and antimicrobial stewardship, while retained susceptibility to last-resort agents offer actionable guidance for empirical therapy.
- 24 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1613
Open AccessVirulence Gene Profile and Antimicrobial Susceptibility of Staphylococcus aureus Clinical Isolates from the United Arab Emirates
Staphylococcus aureus causes infections ranging from skin and soft tissue infections to life-threatening systemic disease. The convergence of virulence determinants with antimicrobial resistance, particularly in methicillin-resistant S. aureus (MRSA), complicates management. In the United Arab Emirates (UAE), S. aureus is a major contributor to community- and hospital-acquired infections, and regional surveillance from the Gulf Cooperation Council has documented a shift toward community-associated MRSA lineages. Despite this clinical burden, granular molecular epidemiological data from the UAE remain scarce. Fifty consecutive S. aureus clinical isolates were obtained from Thumbay Laboratories, Ajman, UAE (October 2022–August 2023). Identification and antimicrobial susceptibility testing against 23 agents were performed on the MicroScan WalkAway system. Five virulence genes, namely mecA, Panton-Valentine leukocidin (PVL; lukF-S), exfoliative toxins A (eta) and B (etb), and toxic shock syndrome toxin (tst), were detected by conventional PCR. PVL was the most prevalent virulence gene (48%, 24/50), detected exclusively in pus isolates. mecA carriage, confirming MRSA, was identified in 44% (22/50), with PVL–mecA co-occurrence in 22% (11/50). eta was present in 6% (3/50), and etb and tst each in 2% (1/50). Resistance was highest for ampicillin and penicillin (86% each), while full susceptibility (100%) was retained for vancomycin, linezolid, daptomycin, teicoplanin, rifampin, Synercid, and trimethoprim. mecA carriage was significantly associated with resistance to amoxicillin, clavulanate, ampicillin, imipenem, penicillin, oxacillin, azithromycin, erythromycin, and ciprofloxacin (p < 0.05). This study provides the first integrated molecular characterization of key S. aureus virulence determinants, along with a comprehensive antimicrobial susceptibility profile in the UAE. The high PVL prevalence and substantial MRSA burden highlight the need for structured regional surveillance and antimicrobial stewardship, while retained susceptibility to last-resort agents offer actionable guidance for empirical therapy.
- 14 November 2025
- Published by Elsevier
- p. 579-598
The future of microbes as alternative sources: advancements, challenges, and opportunities
- 14 November 2025
- Published by Elsevier
- p. 579-598
The future of microbes as alternative sources: advancements, challenges, and opportunities
- Open Access
- 13 November 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (11) , 1148
Efflux-Mediated Macrolide Resistance in Clinical Streptococcus Isolates: A Comparative Molecular Study
Background: Efflux-mediated macrolide resistance represents an emerging threat in Streptococcus infections globally. However, molecular epidemiological data from the Gulf region, particularly the United Arab Emirates (UAE), remain limited. This study addresses this knowledge gap by investigating efflux pump resistance mechanisms in clinical Streptococcus isolates. Methods: A cross-sectional study analyzed 100 clinical isolates (99 Streptococcus and 1 Enterococcus) from Thumbay Hospital, Ajman, UAE (October–December 2024). Antimicrobial susceptibility testing for minimum inhibitory concentration (MIC) determination was performed using the DxM 1096 MicroScan WalkAway system (Beckman Coulter Inc., Brea, CA, USA; LabProv4.42). PCR detected mef(A/E), msr(D), and tet(K) resistance genes with sequencing confirmation. Comparative genomic analysis was performed using a total of 30 publicly available Streptococcus genomes: 15 from India and 15 from Saudi Arabia. Statistical analysis employed chi-square tests, Fisher’s exact tests, and multivariate logistic regression with Bonferroni correction (α = 0.05). Results: Among the isolates, erythromycin resistance occurred in 39 isolates (39%, 95% CI: 29.4–49.2%) and clindamycin resistance in 31 isolates (31%, 95% CI: 22.1–40.9%). The mef(A/E) gene was detected in 31 isolates (31%, 95% CI: 22.1–40.9%), and msr(D) in 3 isolates (3%, 95% CI: 0.6–8.5%), with co-occurrence in 3 isolates (3%). No isolates harbored tet(K). Multivariate analysis identified mef(A/E) as the strongest predictor of macrolide resistance (OR = 18.7, 95% CI: 7.9–44.2, p < 0.001). Regional comparison revealed significant differences: mef(A/E) prevalence was 31% (UAE), 87% (India), and 0% (Saudi Arabia) (p < 0.001). Conclusions: This study provides the first molecular characterization of efflux-mediated macrolide resistance in UAE Streptococcus isolates. The predominance of mef(A/E)-mediated resistance with confirmed efflux activity highlights the clinical significance of active surveillance and targeted antimicrobial stewardship in the region.
- 13 November 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (11) , 1148
Open AccessEfflux-Mediated Macrolide Resistance in Clinical Streptococcus Isolates: A Comparative Molecular Study
Background: Efflux-mediated macrolide resistance represents an emerging threat in Streptococcus infections globally. However, molecular epidemiological data from the Gulf region, particularly the United Arab Emirates (UAE), remain limited. This study addresses this knowledge gap by investigating efflux pump resistance mechanisms in clinical Streptococcus isolates. Methods: A cross-sectional study analyzed 100 clinical isolates (99 Streptococcus and 1 Enterococcus) from Thumbay Hospital, Ajman, UAE (October–December 2024). Antimicrobial susceptibility testing for minimum inhibitory concentration (MIC) determination was performed using the DxM 1096 MicroScan WalkAway system (Beckman Coulter Inc., Brea, CA, USA; LabProv4.42). PCR detected mef(A/E), msr(D), and tet(K) resistance genes with sequencing confirmation. Comparative genomic analysis was performed using a total of 30 publicly available Streptococcus genomes: 15 from India and 15 from Saudi Arabia. Statistical analysis employed chi-square tests, Fisher’s exact tests, and multivariate logistic regression with Bonferroni correction (α = 0.05). Results: Among the isolates, erythromycin resistance occurred in 39 isolates (39%, 95% CI: 29.4–49.2%) and clindamycin resistance in 31 isolates (31%, 95% CI: 22.1–40.9%). The mef(A/E) gene was detected in 31 isolates (31%, 95% CI: 22.1–40.9%), and msr(D) in 3 isolates (3%, 95% CI: 0.6–8.5%), with co-occurrence in 3 isolates (3%). No isolates harbored tet(K). Multivariate analysis identified mef(A/E) as the strongest predictor of macrolide resistance (OR = 18.7, 95% CI: 7.9–44.2, p < 0.001). Regional comparison revealed significant differences: mef(A/E) prevalence was 31% (UAE), 87% (India), and 0% (Saudi Arabia) (p < 0.001). Conclusions: This study provides the first molecular characterization of efflux-mediated macrolide resistance in UAE Streptococcus isolates. The predominance of mef(A/E)-mediated resistance with confirmed efflux activity highlights the clinical significance of active surveillance and targeted antimicrobial stewardship in the region.